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A B S T R A CT  
The current outbreak of viral pneumonia in the city of Wuhan, China, was caused by a 
novel coronavirus designated 2019-nCoV, as determined by sequencing the viral RNA 
genome. Among its genome, S protein is surface-exposed and mediates entry into host 
cells. Currently it is one of the main targets for designing antibodies (Abs), therapeutic 
and vaccine. Earlier studies stated that ACE2 (angiotensin converting enzyme 2) could 
facilitate S protein mediated entry for this newly emerged coronavirus. Here we have 
taken an attempt to compare the genetic structure of receptor binding domain within S 
protein of highly pathogenic human coronaviruses (special reference to 2019-nCoV) with 
Bat coronavirus RaTG13. We have compared 2019-nCov receptor binding domain (RBD) 
with other pathogenic human coronaviruses (MERS-CoV and SARS-CoV) and Bat 
coronavirus RaTG13. We found that it is closest to RaTG13 RBD than MERS-CoV and SARS-
CoV. Our study shows that 2019-nCov RBD also has significant identity with pangolin S 
protein RBD. We have also predicted the amino acid residues within RDB those may play 
important role for ACE2 receptor interaction. We identified unique signature for furin 
cleavage in 2019-nCov S protein but not in of other pathogenic human coronaviruses 
(tested here), bat coronavirus RaTG13 or pangolin.  
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1 Introduction 
The Corona Virus Disease 2019 (COVID-19) caused by a novel coronavirus (CoV) named ‘‘2019 
novel coronavirus’’ or ‘‘2019-nCoV’’ is responsible for the recent pneumonia outbreak that 
started in early December, 2019 in Wuhan City, China. Coronaviruses mainly cause respiratory 
and gastrointestinal tract infections and are genetically classified into four major genera: 
Alphacoronavirus, Beta coronavirus, Gamma coronavirus, and Delta coronavirus. The former 
two genera primarily infect mammals, whereas the latter two predominantly infect birds. 
Three highly pathogenic human coronaviruses (CoVs) have been identified so far, including 
Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory 
syndrome (SARS) coronavirus (SARS-CoV), 2019-nCoV (Du et al. 2009, Walls et al. 2020, WHO 
2020). A large number of studies have proved that the pathogen COVID-19 is a novel 
coronavirus, which belongs to the Coronavirus family, Betacoronavirus genus and 
Sarbecovirus subgenus, with a linear single-stranded positive-strand RNA genome of about 30 
kb (Ceraolo and Giorgi, 2020; Li et al., 2020; Lu et al., 2020; Zhou et al., 2020). Coronavirus 
entry into host cells is mediated by the transmembrane spike (S) protein that forms 
homotrimer protruding from the viral surface (Tortorici and Veesler, 2019). S comprises two 
functional subunits N-terminal S1 subunit and a membrane-embedded C-terminal S2 region 
(Wang & Gao 2015). S1 specializes in recognizing host-cell receptors and is normally more 
variable in sequence among different CoVs than the S2 region (Weinstein 2004 & WHO 2016). 
For many CoVs, S is cleaved at the boundary between the S1 and S2 subunits, which remain 
non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 
2003; Burkard et al.,2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014). The distal S1 
subunit comprises the receptor-binding domain and contributes to stabilization of the 
prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery 
(Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 
2016a; Walls et al., 2017b; Yuan et al.,2017). 
Two discrete domains that can fold independently are located in the S1 N- and C-terminal 
portions, both of which can be used for receptor engagement (Modjarrad, et al. 2016). The 
N-terminal domain (NTD), functioning as the entity involved in receptor recognition. In the S1 
subunit, the receptor binding domain (RBD, also called the C terminal domain, CTD) is 
localized in the C-terminal region, spanning 200 amino acids, and structural studies have 
revealed that the RBD consists of two subdomains: the core and external subdomains 
(Modjarrad et al. 2016, Lu et al. 2013, Chen et al. 2013, Wang et al. 2013). In the S2 subunit, 
the heptad repeat (HR) regions are also well characterized (Gao et al. 2013, Lu et al. 2014, Xu 
et al. 2004), and as expected, the HR1 and HR2 of MERS-CoV fold into an intra-hairpin helical 
structure that can assemble trimerically into a six-helix bundle (a trimer of theHR1/HR2 
heterodimer), demonstrating a classical type I membrane fusion process (Harrison, 2015). 
Peptide inhibitors have been designed targeting these HR regions and been proven to be 
effective in vitro and in vivo (Gao et al. 2013, Lu et al. 2014, Channappanavar et al. 2015, Liu 
et al. 2009, Yuan et al. 2004). These studies have provided insight about the characteristics of 
overall S protein structures. We have taken an attempt to further analyse the RBD domain 
and compare 2019-nCov RBD with two highly pathogenic human coronaviruses (MERS and 
SARS-CoV) and RaTG13. We have tried to predict the residues in RBD those are engaged in 
host receptor interaction. This may enhance our understanding of S protein function and 
subsequent design of broadly neutralizing antibodies and vaccine. 
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2 Results and discussion:  
We have characterised 2019-nCov spike protein RBD by conducting multiple sequence 
alignment between 2019-nCov, SARS-CoV, MERS-CoV and RaTG13. The alignment was 
performed using Clustal Omega. It shows that they are having significant identifies in this 
domain (Figure 1, yellow highlighted). However, RaTG13 RBD is closest (97% identity) to 2019-
nCov. Our result is consistent with recent report of Zhou et al. (Zhou et al. 2020) that states 
that 2019-nCov is most closely related to the bat RaTG13, with which it forms a distinct 
lineage from other SARS-CoVs, and that their S glycoproteins share 97% amino acid sequence 
identity.  
Receptor recognition is the first step of viral infection and is a key determinant of host cell 
and tissue tropism. Previous structural work identified 14 positions for binding of SARS-CoV 
to human ACE2. Those are T402, R426, Y436, Y440, Y442, L472, N473, Y475, N479, Y484, T486, 
T487, G488, and Y491 (Li et al., 2005a). Our result shows that 9 out of these 14 positions are 
strictly conserved in 2019-nCov, whereas the other 5 positions are semi-conservative R426/N, 
Y442/L, L472/F, N479/Q, Y484/Q (Figure 1, in red box). The conservation of key contact 
residues could explain the similar binding affinities of 2019-nCov to human ACE2. These 
probably suggest that 2019-nCov is well adapted to the ACE2 ortholog as the 2002–2003 
epidemic strains of SARSCoV. This also explain the efficient transduction efficiency mediated 
by their respective S glycoproteins and the current rapid transmission in humans. 
 
 
 
MERS-CoV       RRAIDCGFNDLSQLHCSYESFDVESGVYSVSSFEAKPSGSVVEQAEG-VECDFSPLLSG- 391 
SARS-CoV       TDAVDCSQNPLAELKCSVKSFEIDKGIYQTSNFRVVPSGDVVRFPNITNLCPFGEVFNAT 332 
2019-nCoV      TDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNAT 345 
Bat            TDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTDSIVRFPNITNLCPFGEVFNAT 345 
                 *:**. : *:: :*: :** ::.*:*..*.*.. *: .:*.  :    * *. ::..  
 
MERS-CoV       TPPQVYNFKRLVFTNCNYNLTKLLSLFSVNDFTCSQISPAAIASNCYSSLILDYFSYPLS 451 
SARS-CoV       KFPSVYAWERKKISNCVADYSVLYNSTFFSTFKCYGVSATKLNDLCFSNVYADSFVVKGD 392 
2019-nCoV      RFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGD 405 
Bat            TFASVYAWNRKRISNCVADYSVLYNSTSFSTFKCYGVSPTKLNDLCFTNVYADSFVITGD 405 
                  .** ::*  ::**  : : * .   .. *.*  :* : : . *::.:  * *    . 
 
MERS-CoV       MKSDLSVSSAGPISQFNYKQSFSNPTCLILATVPHNLTTITKPLKYSYINKCSRLLSDDR 511 
SARS-CoV       DVRQIAPGQTGVIADYNYKLPDDFMGCVLAWNTRNIDATSTGNYNYKYRYLRHGKLRPFE 452 
2019-nCoV      EVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFE 465 
Bat            EVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSKHIDAKEGGNFNYLYRLFRKANLKPFE 465 
                  ::: ..:* *:::***   .   *::  .  :  :.     :* *       *   . 
 
MERS-CoV       TEVPQLVNANQYSPCVSIVPST-VWEDGDYYRKQLSPLEGGGWLVASGSTVAMTEQLQMG 570 
SARS-CoV       RDISNVPFSPDGKPCTP-PALNCYW-----------PLNDYGFYTTTGIGYQPYRVVVLS 500 
2019-nCoV      RDISTEIYQAGSTPCNGVEGFNCYF-----------PLQSYGFQPTNGVGYQPYRVVVLS 514 
Bat            RDISTEIYQAGSKPCNGQTGLNCYY-----------PLYRYGFYPTDGVGHQPYRVVVLS 514 
                ::         .**      .  :           **   *:  : *      . : :. 
 
MERS-CoV       FGITVQYGTDTNSVCPKLEFANDTKIASQLGNCVEYSLYGVSGRGVFQNCTAVGVRQQRF 630 
SARS-CoV       FELL----NAPATVCGP-----KLSTDLIKNQCVNFNFNGLTGTGVLTPSSKRFQPFQQF 551 
2019-nCoV      FELL----HAPATVCGP-----KKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQF 565 
Bat            FELL----NAPATVCGP-----KKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQF 565 
               * :         :**       . .     .:**::.: *::* **:  ..      *:* 
 
Figure 1: Multiple sequence alignment of RBDs of 2019-nCov , SARS-CoV, MERS-CoV and Bat spike (S)proteins. 
And GenBank accession numbers are QHR63250.1 (2019-nCov S), AY278488.2 (SARS-CoV S), AFS88936.1 
(MERS-CoV S) and Bat spike protein QHR63300.2. Asterisks represent fully conserved residues, colons 
represent highly conserved residues, and periods represent lowly conserved residues. Conserved residues 
among 2019-nCov, SARS-CoV, MERS-CoV and Bat are highlighted in yellow. Identical residues between 2019-
nCov, SARS-CoV, and Bat are highlighted in cyan. Identical residues between 2019-nCov and Bat are 
highlighted in aqua colour. Human ACE2 interacting residues are in red box. The alignment was performed 
using Clustal Omega. 
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We have identified unique signature (681 to 684 residues) in 2019-nCov of S protein 
(highlighted with green in figure 2) at the boundary between the S1 and S2 subunits  
(figure 3). This region was reported as furin cleavage site (Walls et al. 2020). We noticed that 
this is conserved among other 2019-nCov isolates (data not shown).  
 
 
MERS-CoV       PRSVRSVPGEMRLASIAFNHPIQV-DQLNSSYFKLSIPTNFSFGVTQEYIQTTIQKVTVD 805 
SARS-CoV       ---LRSTSQKSI---VAYTMSLGADSSIAYSNNTIAIPTNFSISITTEVMPVSMAKTSVD 719 
2019-nCoV      PRRARSVASQSI---IAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVD 737 
Bat            ----RSVASQSI---IAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVD 733 
                   **.  :     :*:.  : . ..:  *  .::*****::.:* * : .:: *.:** 
 
Figure 2: Multiple sequence alignment of C terminal end of S1 subunit of 2019-nCov , SARS-CoV , MERS-CoV  
and Bat spike (S)proteins. And GenBank accession numbers are QHR63250.1 (2019-nCov S), AY278488.2 (SARS-
CoV S), AFS88936.1 (MERS-CoV S) and Bat spike protein QHR63300.2. Asterisks represent fully conserved 
residues, colons represent highly conserved residues, and periods represent lowly conserved residues. 
Conserved residues among 2019-nCov, SARS-CoV, MERS-CoV and Bat are highlighted in yellow. Identical 
residues between 2019-nCov, SARS-CoV, and Bat are highlighted in cyan. Identical residues between 2019-
nCov and Bat are highlighted in aqua colour. Unique motif of 2019-nCov is highlighted in green. . The 
alignment was performed using Clustal Omega. 
 
As this region was absent in SARS-CoV (figure 2) it probably indicates that S1/S2 cleavage 
during S biosynthesis was not necessary for S-mediated entry into the host cell. This polybasic 
cleavage site in S protein of 2019-nCov could putatively expand its tropism and/or enhance 
its transmissibility, compared with SARS-CoV. Earlier mutation study revealed that the 
detection of a polybasic cleavage site in the fusion glycoprotein of SARS-CoV-2 could 
putatively expand its tropism and/or enhance its transmissibility, compared with SARS-CoV 
and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and 
their reported effects on other viruses (Walls et al. 2020). 
 
 
Figure 3: Structural diagram of 2019-CoV S protein (up). It contains S1 subunit and S2 subunit, which were 
divided by the S cleavage sites. FP, fusion peptide; HR, heptad repeat; RBD, receptor‐binding domain, contains 
core binding motif in the external subdomain; signal peptide. Below: Sequence alignment of 2019-nCov , SARS-
CoV , MERS-CoV  and Bat spike (S)proteins displaying common S cleavage site 
 
We have conducted sequence alignment for RBD domain of S protein for 2019-CoV, bat and 
pangolin. It showed that they have higher identity in this region compare to rest of the 
genome. 2019-CoV RBD sequence from 320 to 540 possesses 93% identity with pangolin 
whereas it is ~86% while considering complete spike protein. This is consistent with earlier 
study (Liu et al. 2020). If we are focusing on only the spike RBD, pangolin has probability to 
cross host barriers and infect humans. Recent report indicates that pangolin-associated 
coronaviruses that belong to two sub-lineages of SARS-CoV-2-related coronaviruses, including 
one that exhibits strong similarity to SARS-CoV-2 in the receptor-binding domain (Lam et al. 
2020). The discovery of multiple lineages of pangolin coronavirus and their similarity to 2019-
nCov suggests that pangolins can be considered as possible hosts in the emergence of novel 
coronaviruses. 
Page 5 of 7 
AIJR Preprints 
Available online at preprints.aijr.org 
Rimjhim Dasgupta, AIJR Preprints, 118, version 1, 2020 
Pangolin       CTLKSLTVEKGIYQTSNFRVQPTISIVRFPNITNLCPFGEVFNASKFASVYAWNRKRISN 358 
2019-nCov      CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN 360 
RaTG13         CTLKSFTVEKGIYQTSNFRVQPTDSIVRFPNITNLCPFGEVFNATTFASVYAWNRKRISN 360 
               *****:***************** ********************: ************** 
 
Pangolin       CVADYSVLYNSTSFSTFKCYGVSPTKLNDLCFTNVYADSFVVKGDEVRQIAPGQTGVIAD 418 
2019-nCov      CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD 420 
RaTG13         CVADYSVLYNSTSFSTFKCYGVSPTKLNDLCFTNVYADSFVITGDEVRQIAPGQTGKIAD 420 
               ***********:*****************************: ************* *** 
 
Pangolin       YNYKLPDDFTGCVIAWNSVKQDALTGGNYGYLYRLFRKSKLKPFERDISTEIYQAGSTPC 478 
2019-nCov      YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC 480 
RaTG13         YNYKLPDDFTGCVIAWNSKHIDAKEGGNFNYLYRLFRKANLKPFERDISTEIYQAGSKPC 480 
               ****************** : *:  ***:.********::*****************.** 
 
Pangolin       NGQVGLNCYYPLERYGFHPTTGVNYQPFRVVVLSFELLNGPATVCGPKLSTTLVKDKCVN 538 
2019-nCov      NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN 540 
RaTG13         NGQTGLNCYYPLYRYGFYPTDGVGHQPYRVVVLSFELLNAPATVCGPKKSTNLVKNKCVN 540 
               **  *:***:**  *** ** **.:**:**********:.******** **.***:**** 
 
Figure 4: Multiple sequence alignment of RBDs of 2019-nCov (QHR63250.2), Pangolin (QIA48632.1) Bat 
QHR63300.2. Asterisks represent fully conserved residues, colons represent highly conserved residues, and 
periods represent lowly conserved residues. Conserved residues among 2019-nCov), Pangolin, and Bat are 
highlighted in yellow. Identical residues between 2019-nCov and Bat are highlighted in cyan. Identical residues 
between 2019-nCov and Pangolin are highlighted in aqua. The alignment was performed using Clustal Omega. 
 
As mentioned earlier previous structural work (Li et al., 2005a) identified 14 positions for 
binding of SARS-CoV to human ACE2. Those are T402, R426, Y436, Y440, Y442, L472, N473, 
Y475, N479, Y484, T486, T487, G488, and Y491 (marked red box in Figure: 1). Our result 
showed that 9 out of these 14 positions are strictly conserved in 2019-nCov, whereas the 
other 5 positions are semi-conservative R426/N, Y442/L, L472/F, N479/Q, Y484/Q (Figure 1, 
in red box). We have marked the corresponding residues of 2019-nCov in figure 4 (in red box) 
along with respective pangolin and BaTG13 residues. Our alignment result suggests that 
pangolin is more related to 2019-CoV RBD than RatG13 with respect to ACE2 binding 
residues. Moreover, the ability to engage ACE2 from different animal species appears to 
reflect host susceptibility to SARS-CoV infection and facilitated the jump of the virus from 
animals to humans (Li,2008; Li et al., 2004). It was reported (Walls et al. 2020) that SARS-CoV-
2 uses hACE2 as an entry receptor and recognizes it with a similar affinity to the 2002–2003 
SARS-CoV isolates. This suggests that it can spread efficiently in humans, in agreement with 
the numerous SARS-CoV-2 human-to-human transmission events reported to date. 
 
Pangolin       ECDIPVGAGICASYHSMS----SFRSVNQRSIIAYTMSLGAENSVAYSNNSIAIPTNFTI 714 
2019-nCov      ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI 720 
RaTG13         ECDIPIGAGICASYQTQTNS----RSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI 716 
 
Figure 5: Multiple sequence alignment of C terminal of S1 subunit 2019-nCov (QHR63250.2), Pangolin 
(QIA48632.1) Bat QHR63300.2. Asterisks represent fully conserved residues, colons represent highly conserved 
residues, and periods represent lowly conserved residues. Conserved residues among 2019-nCov, Pangolin, 
and Bat are highlighted in yellow. Identical residues between 2019-nCov and Bat are highlighted in cyan. 
Unique motif of 2019-nCov is highlighted in green. The alignment was performed using Clustal Omega. 
 
Another recent study (Tai et al. 2020) showed that SARS-CoV-2 RBD protein exhibits strong 
binding to its cell-associated and soluble ACE2 receptors with human and bat origin. This RBD 
domain also demonstrated significantly higher binding affinity to ACE2 than SARS-CoV RBD. 
SARS-CoV-2 RBD protein could block S protein mediated SARS-CoV-2 pseudovirus and SARS-
CoV pseudo virus entry into their respective ACE2 receptor expressing target cells, suggesting 
the potential of SARS-CoV-2 RBD protein as a viral attachment or entry inhibitor against SARS-
CoV-2 and SARS-CoV (Tai et al. 2020). 
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3 Conclusion 
 All together our results provide a structural analysis to identify conserved regions in RBD 
across S proteins that will support ongoing research and vaccine design efforts. We identified 
the amino acid residues within RDB which may play important role for binding ACE2 receptor. 
It suggests that 2019-nCov can spread efficiently in humans, in agreement with the numerous 
2019-nCov human-to-human transmission events reported to date. It underscores the 
importance of continued surveillance of coronaviruses at the sequence and functional levels 
to better prepare for the future. 
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